Search - tctmd.com

Displaying 21 - 40 of 458

Sort: Relevancy | Date

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

Presenter: Yuanji Ma

October 29, 2024

Presentation TCT 2024

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

Presenter: Jiasheng Yin

October 29, 2024

Presentation TCT 2024

TCT 494: Between a Stent and a Hard Place: Insights Into Percutaneous Coronary Interventions and In-Stent Restenosis in Cancer Patients

Presenter: Teodora Donisan

October 29, 2024

Presentation TCT 2024

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Jennifer Tremmel

October 29, 2024

Presentation TCT 2024

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

Presenter: Leonardo Sinnott Silva

October 29, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

1. Clinical Challenges in Complex PCI and In-Stent Restenosis (ISR)

Presenter: Darshan Doshi

October 28, 2024

Presentation TCT 2024

TCT 488: Factors Associated With Chronic Stent Recoil and Its Impact on Revascularization: A Serial Optical Coherence Tomography Study

Presenter: Yoichiro SUGIZAKI

October 28, 2024

Presentation TCT 2024

TCT 491: AGENT Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis in Small Vessel Coronary Lesions: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Suhail Dohad

October 28, 2024

Presentation TCT 2024

TCT 489: The Comparison of Tissue Characteristics of Restenosis After Coronary Interventions: Insights From a Histological Analysis After Directional Coronary Atherectomy

Presenter: Norihito Nakamura

October 28, 2024

Presentation TCT 2024

TCT 487: Preclinical Evaluation of a Novel Cryo-Balloon in the Porcine Coronary Model of In-Stent Restenosis

Presenter: Han Chen

October 28, 2024

Presentation TCT 2024

TCT 490: Intravascular Brachytherapy for Multilayer In-Stent Restenosis: 3-Year Clinical Outcomes

Presenter: Vishal Dhulipala

October 28, 2024

Presentation TCT 2024

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

Presenter: NULL

October 28, 2024

Presentation TCT 2024

TCT 446: Long-term Outcomes and Impact of Diabetes Mellitus in Patients Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Presenter: Gakuto Bando

October 28, 2024

Presentation TCT 2024

Update on Clinical Trial Data With DCB in ISR

Presenter: Bruno Scheller

October 28, 2024

Presentation TCT 2024

How Essential is Intravascular Imaging to the DCB Toolkit?

Presenter: Fernando Alfonso

October 28, 2024

Presentation TCT 2024

Practical Considerations: DCB vs Repeat Stenting With DES

Presenter: Kyung Woo Park

October 28, 2024

Advertisement

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

TCT 494: Between a Stent and a Hard Place: Insights Into Percutaneous Coronary Interventions and In-Stent Restenosis in Cancer Patients

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

1. Clinical Challenges in Complex PCI and In-Stent Restenosis (ISR)

TCT 488: Factors Associated With Chronic Stent Recoil and Its Impact on Revascularization: A Serial Optical Coherence Tomography Study

TCT 491: AGENT Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis in Small Vessel Coronary Lesions: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 489: The Comparison of Tissue Characteristics of Restenosis After Coronary Interventions: Insights From a Histological Analysis After Directional Coronary Atherectomy

TCT 487: Preclinical Evaluation of a Novel Cryo-Balloon in the Porcine Coronary Model of In-Stent Restenosis

TCT 490: Intravascular Brachytherapy for Multilayer In-Stent Restenosis: 3-Year Clinical Outcomes

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

TCT 446: Long-term Outcomes and Impact of Diabetes Mellitus in Patients Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Update on Clinical Trial Data With DCB in ISR

How Essential is Intravascular Imaging to the DCB Toolkit?

Practical Considerations: DCB vs Repeat Stenting With DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content